The financials
Novanta Inc. by the numbers
Novanta Inc. (NOVT) reported revenue of $258M in Q1 2026 (quarter ended April 3, 2026), up 10% from the same quarter a year earlier. That came with a gross margin of 44% and net income of $21M (8.2% of revenue). For the full year FY2025, revenue was $981M (+3.3% year on year) and net income $54M. Its largest segment in 2026-Q1 was Robotics And Automation at $84M, 33% of the disclosed total, just ahead of Precision Medicine at 25%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $258M | $233M | +10% |
| Gross profit | $114M | $104M | +8.8% |
| Operating income | $28M | $32M | −15% |
| Net income | $21M | $21M | −0.5% |
| Diluted EPS | $0.51 | $0.59 | −14% |
| Operating | Revenue | Share |
|---|---|---|
| Robotics And Automation | $84M | 33% |
| Precision Medicine | $64M | 25% |
| Advanced Surgery | $63M | 24% |
| Precision Manufacturing | $47M | 18% |
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Q1 2026Total $257.7M
Precision Medicine grew +18% year on yearPrecision Manufacturing +5.6% year on year
Segment Latestyear on year
- Robotics And Automation$84.2M$84.2Myear on year +7.1%+7.1%
- Precision Medicine$63.9M$63.9Myear on year +18%+18%
- Advanced Surgery$62.5M$62.5Myear on year +11%+11%
- Precision Manufacturing$47.1M$47.1Myear on year +5.6%+5.6%
Scientific & Technical Instruments
Ranks #16 of 16 by Smart Score